This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
C3_EYE_BRAIN_NEURO_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
2877 |
6. Filter based on genotype QC (FinnGen only) |
2877 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2877 | 1338 | 1539 |
| Unadjusted period prevalence (%) | 0.58 | 0.46 | 0.68 |
| Median age at first event (years) | 59.52 | 56.66 | 61.99 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1473
- Matched controls
- 14728
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01AX03
ATC
temozolomide; systemic
+∞
323.0
623
*
A03FA01
ATC
metoclopramide; systemic, rectal
15.3
323.0
695
812
N03AX14
ATC
levetiracetam; systemic
62.3
323.0
521
128
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
28.6
323.0
719
475
A04AA02
ATC
granisetron; systemic, transdermal
2997.4
323.0
454
*
H02AB02
ATC
dexamethasone; systemic
465.2
323.0
924
53
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
784
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
1927.3
323.0
303
*
WF002
NOMESCO Finland
Radical radiotherapy
653.2
323.0
389
8
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
60.1
323.0
414
95
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
26.6
323.0
587
357
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
2808.9
323.0
721
5
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
736.4
323.0
342
6
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
290.5
269
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
42.3
287.5
361
112
Z51.5
ICD-10 Finland
Palliative care
49.1
271.5
330
86
ZXC95
NOMESCO Finland
Use of surgical navigator
90.6
254.7
280
38
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
465.4
243.5
237
6
XX3DW
NOMESCO Finland
Time consuming IT work
19.1
241.8
387
270
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
235.9
220
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
2336.2
225.9
213
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
223.8
209
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
221.6
207
*
A04AA01
ATC
ondansetron; systemic, rectal
29.6
221.5
304
128
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
594.5
212.7
206
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
199.6
187
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
31.2
197.1
266
103
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
189.8
178
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
28.1
186.3
259
111
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
178.8
168
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
175.6
165
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
894.4
166.1
160
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
162.5
153
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
156.0
147
*
AA1AD
NOMESCO Finland
CT of head and brain
4.8
152.1
663
2130
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
151.7
143
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
528.3
147.2
144
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
140.9
133
*
N03AF02
ATC
oxcarbazepine; oral
16.0
138.7
234
172
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
136.6
129
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
135.5
128
*
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
+∞
133.4
126
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
125.8
119
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
125.8
119
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.1
125.1
475
1266
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.1
123.1
642
2333
ZXC40
NOMESCO Finland
Use of ultrasound
77.9
119.8
135
19
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
626.5
118.9
116
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
1232.9
118.5
114
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
118.3
112
*
N03AX18
ATC
lacosamide; systemic
73.5
117.9
134
20
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
115.1
109
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
113.0
107
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
113.0
107
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1151.1
111.0
107
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
109.8
104
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
+∞
107.6
102
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
107.6
102
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
1070.2
103.5
100
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
21.0
102.6
155
82
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.1
101.1
305
604
N02AA05
ATC
oxycodone; systemic
5.6
100.8
331
727
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.8
98.0
243
365
JN4BD
NOMESCO Finland
Extensive body CT
8.8
96.8
221
291
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
17.5
96.3
155
98
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
95.9
91
*
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
+∞
93.7
89
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.9
93.3
352
895
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
35.5
93.2
121
37
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
92.7
88
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
944.6
91.8
89
*
WX882
NOMESCO Finland
High dependency care
13.0
91.5
167
143
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
90.5
86
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
89.5
85
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.6
88.7
204
270
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
24.1
87.4
126
57
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
17.5
87.0
140
88
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
31.8
84.0
112
38
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
425.2
81.8
81
*
N74
ICPC
Malignant neoplasm nervous system
+∞
79.9
76
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.0
78.7
208
338
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
36.9
77.8
100
29
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.0
77.5
172
213
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
787.7
77.0
75
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
76.7
73
*
A02BC02
ATC
pantoprazole; systemic
2.9
76.4
1054
6843
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
270.7
76.2
77
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
74.6
71
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
73.5
70
*
WX402
NOMESCO Finland
General anaesthesia
4.0
72.3
334
1007
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
70.6
494
2057
WZC30
NOMESCO Finland
Teaching
4.6
69.7
266
667
L03AA02
ATC
filgrastim; parenteral
151.2
68.6
72
5
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
68.2
65
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
68.2
65
*
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
67.2
64
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
65.9
391
1433
AAA10
NOMESCO Finland
Biopsy through craniotomy
666.5
65.4
64
*
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
+∞
65.1
62
*
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
65.1
62
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
9.7
64.7
136
152
L03AA13
ATC
pegfilgrastim; parenteral
+∞
64.0
61
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
41.7
63.2
79
20
N03AB02
ATC
phenytoin; systemic
16.5
62.5
102
66
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
60.8
58
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
309.1
58.7
59
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
23.1
57.2
83
38
G40.10
ICD-10 Finland
Simple partial seizures
28.9
56.7
77
28
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
55.6
53
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
55.6
53
*
ZXM40
NOMESCO Finland
Use of fluorescent substance
286.5
54.5
55
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
53.6
637
3503
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
+∞
53.4
51
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
118.5
53.2
57
5
A79
ICPC
Malignancy NOS
536.3
52.8
52
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
51.3
49
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
50.3
48
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
50.3
48
*
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
50.3
48
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
26.7
49.8
69
27
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
+∞
49.2
47
*
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
+∞
48.2
46
*
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
48.2
46
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
48.2
46
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
47.1
45
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
20.9
47.0
70
35
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
46.1
44
*
8000/3-C71.9
ICD-O-3
Neoplasm, malignant of brain, NOS
+∞
46.1
44
*
115
Kela drug reimbursment
Breast cancer
+∞
46.1
44
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
45.6
577
3200
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.0
45.3
131
235
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
44.0
42
*
H53.4
ICD-10 Finland
Visual field defects
9.3
43.6
93
106
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
12.4
43.1
79
67
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
226.5
43.1
44
*
9450/3-C71.1
ICD-O-3
Oligodendroglioma, NOS, of frontal lobe
+∞
42.9
41
*
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
41.9
40
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
41.9
40
*
H02AB09
ATC
hydrocortisone; systemic
8.4
40.4
91
114
N76
ICPC
Neoplasm nervous system unspecified
210.6
40.0
41
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
39.8
38
*
N05BA09
ATC
clobazam; oral
20.4
39.4
59
30
N03AF01
ATC
carbamazepine; oral, rectal
4.6
39.4
144
337
WX872
NOMESCO Finland
Intensive care
4.7
38.3
136
309
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
386.9
38.2
38
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
37.7
36
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
37.7
36
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
37.5
345
1597
WX140
NOMESCO Finland
Parabulbar anesthesy
5.0
36.8
124
266
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
36.6
35
*
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
36.6
35
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
36.6
35
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
27.2
36.5
50
19
A28
ICPC
Limited function/disability NOS
2.8
36.4
274
1128
JN4AD
NOMESCO Finland
Body CT examination
5.9
36.2
105
189
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
35.6
34
*
WW500
NOMESCO Finland
Blood transfusion
7.6
35.4
85
118
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
11.9
35.0
65
57
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
34.5
33
*
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
+∞
34.5
33
*
N03AG01
ATC
valproic acid; systemic, rectal
3.7
33.9
156
451
WX110
NOMESCO Finland
Local anesthesy
2.0
33.8
980
7351
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
+∞
33.5
32
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
33.5
32
*
R4110
NOMESCO Finland
Physiotherapy
2.2
33.3
405
2136
N05CD08
ATC
midazolam; nasal, systemic
6.9
33.1
85
130
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
334.2
33.0
33
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
32.4
31
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
32.4
31
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
32.4
31
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
32.4
31
*
JN4CD
NOMESCO Finland
Very extensive body CT
9.2
32.1
68
77
B01AB10
ATC
tinzaparin; parenteral
4.8
31.8
111
247
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
31.4
30
*
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
+∞
31.4
30
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
31.4
30
*
XW000
NOMESCO Finland
Bone marrow biopsy
6.6
31.1
82
130
TAB00
NOMESCO Finland
Lumbar puncture
4.5
30.7
113
266
N05CF01
ATC
zopiclone; oral
2.0
30.3
494
2933
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
30.3
29
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
308.3
29.9
30
*
9450/3-C71.9
ICD-O-3
Oligodendroglioma, NOS, of brain, NOS
+∞
29.3
28
*
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
29.3
28
*
WX002
NOMESCO Finland
Sedation and analgesia
2.3
28.8
316
1572
ZXA05
NOMESCO Finland
Left side
2.1
28.7
388
2125
D70.82
ICD-10 Finland
Drug-induced neutropenia
26.6
28.5
39
15
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
28.2
27
*
ZXA00
NOMESCO Finland
Right side
2.1
27.9
408
2306
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
286.6
27.8
28
*
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
102.0
27.7
30
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
27.6
172
622
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
27.2
26
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
42.1
26.8
33
8
183
Kela drug reimbursment
Lamotrigin and topiramate
11.0
26.6
51
48
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
26.4
598
3960
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
26.3
254
1182
XCK10
NOMESCO Finland
Photography of fundus of eye
2.7
26.3
191
761
WX704
NOMESCO Finland
Intubation
3.3
26.2
138
443
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
26.1
25
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
26.1
264
1259
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
14.7
25.8
43
30
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.9
25.6
73
129
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
28.9
25.4
34
12
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.9
25.3
168
633
R4150
NOMESCO Finland
Neuropsychological rehabilitation
13.3
25.2
44
34
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
+∞
25.1
24
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
24.9
150
527
G91.1
ICD-10 Finland
Obstructive hydrocephalus
32.7
24.7
32
10
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
24.0
23
*
9401/3-C71.1
ICD-O-3
Astrocytoma, anaplastic, NOS, of frontal lobe
+∞
24.0
23
*
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
+∞
24.0
23
*
116
Kela drug reimbursment
Prostate cancer
+∞
24.0
23
*
B01AB05
ATC
enoxaparin; parenteral
2.0
23.9
383
2220
CAA30
NOMESCO Finland
Biopsy of orbit
127.0
23.6
25
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.1
23.1
46
47
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
23.0
22
*
AA5FG
NOMESCO Finland
Functional MRI examination of brain with high intensity magnet
233.4
22.7
23
*
HAC20
NOMESCO Finland
Total mastectomy
121.9
22.6
24
*
A98
ICPC
Health maint/preventive medicine
0.5
22.6
1108
12608
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
9.5
22.4
46
50
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.8
22.3
30
11
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
21.9
21
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
21.9
21
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
21.9
21
*
Z2445
NOMESCO Finland
Psychologist
3.7
21.8
97
272
Z2446
NOMESCO Finland
Social worker
3.1
21.6
127
438
R4120
NOMESCO Finland
Occupational therapy
3.0
21.4
131
465
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.0
21.4
53
78
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
21.2
265
1379
G41.9
ICD-10 Finland
Status epilepticus, unspecified
15.8
21.1
34
22
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
+∞
20.9
20
*
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
20.9
20
*
9451/3-C71.1
ICD-O-3
Oligodendroglioma, anaplastic, NOS, of frontal lobe
+∞
20.9
20
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
8.4
20.5
45
55
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
42.3
20.5
25
6
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.1
20.2
114
384
CF2S4
NOMESCO Finland
Photography of conjunctiva
58.3
19.9
23
*
C71
ICD-10 Finland
Malignant neoplasm of brain
+∞
19.8
19
*
C71.70
ICD-10 Finland
Malignant tumor of the brainstem without histology
+∞
19.8
19
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
19.8
19
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
19.8
19
*
9440/3-C71.0
ICD-O-3
Glioblastoma, NOS, of cerebrum
+∞
19.8
19
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
74.5
19.7
22
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
14.2
19.1
32
23
Z3231
NOMESCO Finland
Registered nurse
1.8
18.9
385
2400
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
18.8
18
*
9401/3-C71.9
ICD-O-3
Astrocytoma, anaplastic, NOS, of brain, NOS
+∞
18.8
18
*
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
18.8
18
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
18.8
18
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
+∞
18.8
18
*
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
+∞
18.8
18
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
70.8
18.7
21
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
101.3
18.6
20
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.6
18.2
27
14
180
Kela drug reimbursment
Interferon alfa
+∞
17.7
17
*
C71.02
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles grade III glioma
+∞
17.7
17
*
C71.0
ICD-10 Finland
Malignant neoplasm: Cerebrum, except lobes and ventricles
+∞
17.7
17
*
9401/3-C71.2
ICD-O-3
Astrocytoma, anaplastic, NOS, of temporal lobe
+∞
17.7
17
*
C71.65
ICD-10 Finland
Malignant tumor of the cerebellum primary neuroectodermal tumor
+∞
17.7
17
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.3
17.6
42
59
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
182.0
17.5
18
*
SPAT1153
SPAT
Removal of sutures
1.7
17.0
403
2624
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
16.7
16
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
16.7
16
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
16.7
16
*
C69.21
ICD-10 Finland
Retina
+∞
16.7
16
*
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
16.7
16
*
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
+∞
16.7
16
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
16.7
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.7
16.7
48
87
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
16.7
253
1414
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
7.8
16.7
38
50
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
23.3
16.4
23
10
WX725
NOMESCO Finland
Noninvasive ventilation
3.4
16.4
81
248
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
16.4
141
613
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
30.4
16.1
21
7
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.0
16.1
36
46
HA1AA
NOMESCO Finland
X-ray mammography
4.6
16.1
56
126
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
8.7
16.0
34
40
R50.9
ICD-10 Finland
Fever, unspecified
2.1
15.8
189
959
N03AX23
ATC
brivaracetam; systemic
33.7
15.7
20
6
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
15.7
142
632
ZX120
NOMESCO Finland
Intravenous
2.6
15.7
118
476
9382/3-C71.1
ICD-O-3
Oligoastrocytoma, NOS, of frontal lobe
+∞
15.6
15
*
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.6
15
*
G93.6
ICD-10 Finland
Cerebral oedema
+∞
15.6
15
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
15.6
15
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
15.6
15
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
15.6
15
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
15.6
15
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
15.6
15
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
15.6
15
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
15.6
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.6
15
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
26.6
15.6
21
8
D69.5
ICD-10 Finland
Secondary thrombocytopenia
26.6
15.6
21
8
WW409
NOMESCO Finland
Other aferesis
161.6
15.5
16
*
N05BA04
ATC
oxazepam; oral
1.7
15.3
342
2173
G40.89
ICD-10 Finland
Other epilepsy
16.2
15.2
24
15
L28
ICPC
Limited function/disability (L)
2.0
15.2
216
1176
JN6AD
NOMESCO Finland
CT of torso and neck
17.9
15.2
23
13
R4130
NOMESCO Finland
Speech therapy
4.7
15.2
51
111
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
7.9
15.1
34
44
G40
ICD-10 Finland
Epilepsy
7.4
15.0
35
48
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
15.0
166
816
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
14.8
85
290
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
25.3
14.7
20
8
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.4
14.6
38
61
9440/3-C71.8
ICD-O-3
Glioblastoma, NOS, of overlapping lesion of brain
+∞
14.6
14
*
L02BB03
ATC
bicalutamide; oral
+∞
14.6
14
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
+∞
14.6
14
*
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
14.6
14
*
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
14.6
14
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
+∞
14.6
14
*
3779
FHL
Other operations in this group include disc removal
+∞
14.6
14
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
151.4
14.5
15
*
N03AX22
ATC
perampanel; oral
36.4
14.4
18
5
ZXD05
NOMESCO Finland
Urgent procedure
1.6
14.1
418
2867
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.2
14.1
75
244
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.3
14.0
51
121
N02BE01
ATC
paracetamol; systemic, rectal
1.6
13.7
1146
10067
2151
FHL
Resection, big brain
75.8
13.6
15
*
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
+∞
13.6
13
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
11.0
13.5
25
23
A04AD12
ATC
aprepitant; systemic
141.2
13.5
14
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
16.4
13.5
21
13
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
26.0
13.4
18
7
G41.2
ICD-10 Finland
Complex partial status epilepticus
40.4
13.2
16
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
13.1
137
655
XCK00
NOMESCO Finland
Perimetry
2.5
13.1
103
428
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
22.7
12.9
18
8
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
50.4
12.8
15
*
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
32.3
12.6
16
5
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.6
12.6
36
66
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
12.5
12
*
9470/3-C71.6
ICD-O-3
Medulloblastoma, NOS, of cerebellum, NOS
+∞
12.5
12
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
12.5
12
*
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
+∞
12.5
12
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
12.5
12
*
C71.51
ICD-10 Finland
Malignant tumor of cerebral ventricle ependymoma
+∞
12.5
12
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
12.5
12
*
C69.20
ICD-10 Finland
Retina
+∞
12.5
12
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
12.5
12
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
12.5
12
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
12.5
12
*
WX892
NOMESCO Finland
Monitored bed care
2.3
12.5
116
524
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
131.0
12.4
13
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
8.1
12.3
27
34
L02AE02
ATC
leuprorelin; implant, parenteral
9.1
12.2
25
28
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.6
12.0
30
46
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
21.5
12.0
17
8
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
21.5
12.0
17
8
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.7
11.9
52
146
N28
ICPC
Limited function/disability (N)
5.0
11.9
37
75
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
47.0
11.9
14
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
47.0
11.9
14
*
A06AD11
ATC
lactulose; oral
1.9
11.8
193
1102
XA400
NOMESCO Finland
EEG
9.0
11.8
24
27
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
9.7
11.7
23
24
R51.80
ICD-10 Finland
Headache
1.9
11.7
193
1105
Z2221
NOMESCO Finland
Medical doctor
1.6
11.6
362
2499
CDC00
NOMESCO Finland
Enucleation of eye
65.4
11.6
13
*
C71.74
ICD-10 Finland
Malignant tumor of the brainstem ependyoma
+∞
11.5
11
*
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
11.5
11
*
C72.9
ICD-10 Finland
Malignant neoplasm: Central nervous system, unspecified
+∞
11.5
11
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
C71.7
ICD-10 Finland
Malignant neoplasm: Brain stem
+∞
11.5
11
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
11.5
11
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
11.5
11
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
11.5
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.5
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
5.6
11.3
32
58
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.6
11.3
38
84
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.2
11.2
59
192
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.9
11.2
66
232
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
25.2
11.1
15
6
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.0
11.1
43
109
Z3226
NOMESCO Finland
Physiotherapist
1.7
11.1
238
1483
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
11.2
11.0
20
18
N18
ICPC
Paralysis/weakness
4.3
11.0
40
96
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
5.0
11.0
34
69
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.3
10.9
28
45
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
43.6
10.9
13
*
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
43.6
10.9
13
*
SPAT1229
SPAT
Assessment of need for aid
2.2
10.8
108
507
ZX112
NOMESCO Finland
Subcutaneous
7.2
10.8
25
35
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
5.9
10.7
29
50
CS494
NOMESCO Finland
Other visual field testing
4.0
10.6
41
104
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
60.4
10.6
12
*
AA5JS
NOMESCO Finland
Extensive PET-MRI of brain metabolism
110.7
10.4
11
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
10.4
10
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
10.4
10
*
9450/3-C71.3
ICD-O-3
Oligodendroglioma, NOS, of parietal lobe
+∞
10.4
10
*
Y77
ICPC
Malignant neoplasm prostate
+∞
10.4
10
*
1CD02
NOMESCO Finland
NA
+∞
10.4
10
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
10.4
10
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.4
10
*
9382/3-C71.9
ICD-O-3
Oligoastrocytoma, NOS, of brain, NOS
+∞
10.4
10
*
ZX131
NOMESCO Finland
Intrathecal
+∞
10.4
10
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
10.4
10
*
9450/3-C71.2
ICD-O-3
Oligodendroglioma, NOS, of temporal lobe
+∞
10.4
10
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
10.4
10
*
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
+∞
10.4
10
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
10.4
10
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.8
10.4
67
250
TPX15
NOMESCO Finland
Removal of vascular injection port
16.2
10.4
16
10
A06AH03
ATC
naloxegol; oral
12.1
10.3
18
15
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
10.3
222
1381
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
7.2
10.3
24
34
L02BA01
ATC
tamoxifen; oral
18.9
10.3
15
8
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
10.2
142
763
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
10.2
122
2075
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
10.1
88
387
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
3.8
10.1
42
114
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.1
10.0
26
43
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.6
10.0
125
2099
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
40.3
10.0
12
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
9.9
64
240
N03AX11
ATC
topiramate; oral
3.6
9.9
43
122
CH2S4
NOMESCO Finland
Photography of iris
55.3
9.7
11
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
9.6
95
444
A07AA02
ATC
nystatin; oral
2.4
9.6
82
358
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
9.5
72
1404
D33.43
ICD-10 Finland
Spinal cord
100.6
9.4
10
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
30.2
9.4
12
*
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
30.2
9.4
12
*
3AA13
NOMESCO Finland
NA
+∞
9.4
9
*
C71.61
ICD-10 Finland
Malignant tumor of cerebellum grade II glioma
+∞
9.4
9
*
C71.92
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade III glioma
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
C69.29
ICD-10 Finland
Retina
+∞
9.4
9
*
C71.79
ICD-10 Finland
Malignant tumor of the brainstem other or unspecified histology
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
N03AF04
ATC
eslicarbazepine; oral
+∞
9.4
9
*
AA003
NOMESCO Finland
Adjuvant radiotherapy of brain
+∞
9.4
9
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
X76
ICPC
Malignant neoplasm breast female
+∞
9.4
9
*
C71.42
ICD-10 Finland
Malignant tumor of the occipital lobe grade III glioma
+∞
9.4
9
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
H53.2
ICD-10 Finland
Diplopia
3.0
9.3
53
181
1XC02
NOMESCO Finland
NA
10.7
9.3
17
16
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.0
9.2
50
168
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
9.1
101
498
H47.1
ICD-10 Finland
Papilloedema, unspecified
11.5
9.1
16
14
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
9.1
66
1298
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
9.0
149
853
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
9.0
128
2086
CD2S4
NOMESCO Finland
Photography of eye
8.7
8.8
18
21
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
10.8
8.8
16
15
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.7
8.7
36
98
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
8.7
81
369
S18
ICPC
Laceration/cut
1.4
8.7
488
3791
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
50.3
8.7
10
*
F80.1
ICD-10 Finland
Expressive language disorder
6.6
8.7
21
32
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
8.6
659
7791
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.6
8.6
139
2198
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.3
8.6
25
48
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
11.6
8.6
15
13
WX730
NOMESCO Finland
Conventional respirator
3.7
8.5
35
95
Z97.0
ICD-10 Finland
Presence of artificial eye
27.7
8.5
11
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
27.7
8.5
11
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.6
8.5
138
2176
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
3.9
8.5
33
86
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
90.5
8.4
9
*
C69.2
ICD-10 Finland
Malignant neoplasm: Retina
+∞
8.3
8
*
9391/3-C71.7
ICD-O-3
Ependymoma, NOS, of brain stem
+∞
8.3
8
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
8.3
8
*
AA5FK
NOMESCO Finland
Functional assessment (fMRI) of brain
+∞
8.3
8
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
8.3
8
*
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
8.3
8
*
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
8.3
8
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
8.3
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
8.3
8
*
9445/3-C71.9
ICD-O-3
Glioblastoma, IDH-mutant of brain, NOS
+∞
8.3
8
*
C71.49
ICD-10 Finland
Malignant tumor in occipital lobe other or unspecified histology
+∞
8.3
8
*
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
+∞
8.3
8
*
1911X
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]
+∞
8.3
8
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
8.3
8
*
19003
ICD-8 Finland
Malignant neoplasm of eye, Retinae
+∞
8.3
8
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
8.3
8
*
R41.0
ICD-10 Finland
Disorientation, unspecified
2.7
8.1
52
195
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
33.5
8.1
10
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.1
8.0
24
48
ZXD35
NOMESCO Finland
Usual procedure
2.6
8.0
56
221
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
22.1
8.0
11
5
RS221
NOMESCO Finland
NA
4.0
8.0
30
76
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
7.3
8.0
18
25
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.3
7.9
72
324
C10AX09
ATC
ezetimibe; oral
0.4
7.9
36
833
R83
ICPC
Respiratory infection other
0.6
7.9
129
2033
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
8.5
7.8
16
19
ZXE00
NOMESCO Finland
One hour or less
1.4
7.8
475
3728
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
45.2
7.7
9
*
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.4
7.7
41
898
ZX121
NOMESCO Finland
Central venous catheter
18.4
7.6
11
6
N02AA01
ATC
morphine; systemic, rectal
6.7
7.6
18
27
ZZR00
NOMESCO Finland
Flap of skin
6.7
7.6
18
27
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
11.9
7.6
13
11
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
25.1
7.6
10
*
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
25.1
7.6
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
25.1
7.6
10
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
10.1
7.5
14
14
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
80.5
7.4
8
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
80.5
7.4
8
*
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
80.5
7.4
8
*
R4190
NOMESCO Finland
Nutritional therapy
2.9
7.4
43
152
XX8XW
NOMESCO Finland
NA
13.4
7.4
12
9
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.4
86
435
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.7
7.3
251
3406
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
7.3
74
352
H01AC01
ATC
somatropin; parenteral
8.4
7.3
15
18
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
8.4
7.3
15
18
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
7.3
92
480
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
10.9
7.3
13
12
19107
ICD-8 Finland
Malignant neoplasm of brain, Cerebelli
+∞
7.3
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
8000/3-C71.2
ICD-O-3
Neoplasm, malignant of temporal lobe
+∞
7.3
7
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
7.3
7
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
8000/3-C71.1
ICD-O-3
Neoplasm, malignant of frontal lobe
+∞
7.3
7
*
C71.73
ICD-10 Finland
Malignant tumor of the brain stem grade IV glioma
+∞
7.3
7
*
L01CB01
ATC
etoposide; systemic
+∞
7.3
7
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
D43
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of brain and central nervous system
+∞
7.3
7
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
7.3
7
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
7.3
7
*
9530/3-C70.0
ICD-O-3
Meningioma, malignant of cerebral meninges
+∞
7.3
7
*
1BC01
NOMESCO Finland
NA
+∞
7.3
7
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
7.3
7
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
7.3
7
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
7.3
7
*
C71.63
ICD-10 Finland
Malignant tumor of cerebellum grade IV glioma
+∞
7.3
7
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
4.5
7.3
24
54
ZXY02
NOMESCO Finland
Neuropsychologist
6.3
7.2
18
29
C10AA05
ATC
atorvastatin; oral
0.7
7.2
289
3815
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
30.1
7.1
9
*
WF099
NOMESCO Finland
Other radiotherapy
20.1
7.1
10
5
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
20.1
7.1
10
5
C10AA07
ATC
rosuvastatin; oral
0.6
7.1
144
2165
G41.0
ICD-10 Finland
Grand mal status epilepticus
12.1
7.1
12
10
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
12.1
7.1
12
10
CBA10
NOMESCO Finland
Biopsy of eyelid
6.1
7.1
18
30
CA1ME
NOMESCO Finland
Ultrasound oculometry
6.1
7.1
18
30
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.3
7.1
33
101
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
7.0
321
4151
M03BX01
ATC
baclofen; systemic
3.5
7.0
30
86
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
7.0
26
66
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
7.0
72
347
N29
ICPC
Neurological sympt/complt other
3.4
6.9
31
92
ZX108
NOMESCO Finland
Inhalation
7.6
6.9
15
20
CKA10
NOMESCO Finland
Biopsy of vitreous body
13.8
6.9
11
8
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
13.8
6.9
11
8
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
6.9
71
342
NK6AN
NOMESCO Finland
Total body bone isotope imaging
11.0
6.8
12
11
DFF20
NOMESCO Finland
Audiometry for children
11.0
6.8
12
11
AA1AA
NOMESCO Finland
Head X-ray examination
6.1
6.8
17
28
2159
FHL
Other measure in this category
40.2
6.8
8
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
40.2
6.8
8
*
C07AB07
ATC
bisoprolol; oral
0.7
6.8
392
4894
M25.5
ICD-10 Finland
Pain in joint
0.7
6.8
176
2520
GD1AA
SPAT
NA
0.3
6.7
13
437
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.0
6.7
*
167
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.9
6.6
38
132
R03AC02
ATC
salbutamol; inhalant
0.7
6.6
445
5439
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.5
6.6
29
85
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.2
6.6
66
311
WW200
SPAT
NA
0.5
6.6
39
822
SPAT1109
SPAT
Analgesia with portable analgesic pump
12.3
6.6
11
9
102
Kela drug reimbursment
Diabetes insipidus
12.3
6.6
11
9
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
6.5
56
248
ZX100
NOMESCO Finland
Oral
4.2
6.5
23
56
L02BG04
ATC
letrozole; oral
3.8
6.5
25
66
3102
FHL
Enucleation
70.1
6.4
7
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
70.1
6.4
7
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
7.4
6.4
14
19
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
14.4
6.4
10
7
WX142
NOMESCO Finland
Sub-tenon anesthesy
5.5
6.3
17
31
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.3
6.3
12
13
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
18.1
6.3
9
5
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
18.1
6.3
9
5
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
18.1
6.3
9
5
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
18.1
6.3
9
5
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
6.3
6
*
A04AA03
ATC
tropisetron; systemic
+∞
6.3
6
*
19100
ICD-8 Finland
Malignant neoplasm of brain, Lobi frontalis
+∞
6.3
6
*
9382/3-C71.2
ICD-O-3
Oligoastrocytoma, NOS, of temporal lobe
+∞
6.3
6
*
D33.12
ICD-10 Finland
Cerebellum
+∞
6.3
6
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
6.3
6
*
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
+∞
6.3
6
*
9380/3-C71.1
ICD-O-3
Glioma, malignant of frontal lobe
+∞
6.3
6
*
C71.41
ICD-10 Finland
Malignant tumor of occipital lobe grade II glioma
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
1AC01
NOMESCO Finland
NA
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
6.3
6
*
C71.66
ICD-10 Finland
Malignant tumor of the cerebellum medullobastoma
+∞
6.3
6
*
2312
FHL
Extirpation or destruction
+∞
6.3
6
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
6.3
6
*
1911A
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]
+∞
6.3
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.3
6
*
9391/3-C71.5
ICD-O-3
Ependymoma, NOS, of ventricle, NOS
+∞
6.3
6
*
ZX002
NOMESCO Finland
Simple dose design for radiotherapy based on tomography - isocentric therapy
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
C69.91
ICD-10 Finland
Malignant tumor in unspecified localization in the eye retinoblastoma
+∞
6.3
6
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
6.3
6
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
6.3
6
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
6.3
6
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
9401/3-C71.3
ICD-O-3
Astrocytoma, anaplastic, NOS, of parietal lobe
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
9380/3-C71.2
ICD-O-3
Glioma, malignant of temporal lobe
+∞
6.3
6
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
6.2
100
571
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
6.1
56
256
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.6
6.1
10
8
XX4AW
NOMESCO Finland
NA
8.6
6.1
12
14
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
6.0
61
1091
L03
ICPC
Low back symptom/complaint
0.7
6.0
149
2156
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.6
6.0
120
1814
Z31.5
ICD-10 Finland
Genetic counselling
2.4
6.0
49
211
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
958
634
22.15
307.65
1.4
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
416
115
42.11
307.65
1.8
2.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
534
1018
6.21
275.69
5.4
9.7
mmol/l
24.4
24.3
0.11
525
932
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
159
36
46.68
270.25
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
809
2309
4.48
259.22
7.1
7.1
mmol/l
1.1
1.2
0.10
614
1772
(3027801) Oxygen [Partial pressure] in Arterial blood
807
2327
4.43
254.68
7.1
7.0
kpa
17.0
11.8
74.90
771
2217
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
807
2327
4.43
254.68
7.1
7.1
kpa
5.0
5.1
2.20
770
2217
(3018677) aPTT in Platelet poor plasma by Coagulation assay
906
3217
3.65
207.84
2.2
2.2
s
27.8
30.0
20.76
882
3112
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
107
23
48.27
183.45
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1399
6864
3.02
181.77
2.9
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1250
5857
3.00
175.04
2.7
2.2
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
159
0
+∞
167.33
1.1
0.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1750
10116
2.86
160.80
12.5
3.9
umol/l
10.4
12.2
9.48
1710
9443
(3033658) Prothrombin time (PT) actual/Normal
1097
5016
2.92
157.22
4.4
3.7
%
93.7
88.2
11.89
1066
4875
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
181
193
9.94
154.06
2.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
258
429
6.51
150.19
1.9
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1614
9252
2.69
145.56
8.4
5.4
mmol/l
1.2
1.2
11.70
1551
8218
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
268
490
5.93
141.52
1.9
1.4
e6/l
2507.9
1639.8
0.38
214
409
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
591
1999
3.46
140.72
5.6
3.0
u/l
245.3
235.3
1.09
575
1865
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
267
490
5.90
140.41
1.9
1.4
e6/l
51.5
29.4
0.46
207
390
(3016018) Differential panel - Cerebral spinal fluid
178
213
8.84
138.56
1.8
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1715
10296
2.65
138.04
9.0
5.8
mmol/l
1.2
1.2
8.17
1500
8629
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
279
550
5.51
135.75
1.8
1.3
mg/l
1013.3
505.0
1.89
273
521
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
130
102
13.30
135.54
2.4
2.3
umol/l
54.7
52.5
0.25
114
81
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
979
4510
2.77
134.56
2.6
2.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1278
6998
2.49
119.93
9.4
5.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1816
11761
2.47
115.85
17.7
6.7
e9/l
4.1
4.2
2.23
1604
10109
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
240
491
5.24
111.59
1.7
1.2
mmol/l
3.6
3.9
2.05
230
459
(3013826) Glucose [Moles/volume] in Serum or Plasma
1894
12642
2.46
110.74
7.9
4.4
mmol/l
6.7
6.8
0.65
1837
11744
(3012095) Magnesium [Moles/volume] in Serum or Plasma
699
3026
2.73
104.91
4.2
2.9
mmol/l
0.8
0.8
1.24
664
2779
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
113
108
10.85
103.65
1.8
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
513
1891
3.08
103.59
8.7
7.8
g/l
126.4
122.9
3.58
495
1822
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1472
9084
2.27
99.19
4.5
3.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
536
2086
2.93
97.84
8.9
7.4
%
97.4
95.2
15.40
516
2007
(3022096) Basophils/100 leukocytes in Blood
1502
9591
2.18
89.97
9.9
5.9
%
0.6
0.7
14.72
1451
8869
(3015377) Calcium [Moles/volume] in Serum or Plasma
1135
6507
2.23
88.99
7.7
2.1
mmol/l
2.4
2.4
0.06
1044
5480
(3024561) Albumin [Mass/volume] in Serum or Plasma
1385
8595
2.18
88.90
6.1
4.0
g/l
34.8
35.8
8.27
1312
7877
(3011412) CD3 cells [#/volume] in Blood
117
144
8.42
88.74
2.2
2.2
e9/l
1.0
1.2
0.81
82
81
(3023410) Appearance of Cerebral spinal fluid
138
213
6.75
85.76
1.9
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1523
9909
2.14
85.33
10.2
6.1
%
9.0
8.7
2.96
1475
9201
(3006504) Eosinophils/100 leukocytes in Blood
1517
9864
2.14
85.02
9.9
5.8
%
2.2
2.9
32.70
1465
9113
(3014007) Fractional oxyhemoglobin in Arterial blood
366
1238
3.24
84.63
7.3
9.2
%
95.4
93.5
7.19
366
1233
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1173
6937
2.17
83.83
2.7
2.2
u/l
178.1
228.5
1.29
1140
6493
(3023368) Bacteria identified in Blood by Culture
982
5447
2.22
82.17
5.1
3.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1587
10609
2.11
81.31
9.9
5.6
e9/l
0.6
0.6
2.12
1373
9113
(3006315) Basophils [#/volume] in Blood
1587
10664
2.09
79.51
9.9
5.6
e9/l
0.0
0.0
20.56
1372
9171
(3002030) Lymphocytes/100 leukocytes in Blood
1534
10184
2.08
79.36
10.2
5.9
%
24.7
28.1
26.34
1483
9406
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
94
102
9.49
78.61
2.2
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1603
10914
2.06
76.24
10.0
5.6
e9/l
1.7
1.9
4.33
1395
9540
(3018010) Neutrophils/100 leukocytes in Blood
1512
10081
2.05
76.18
9.9
5.7
%
60.0
57.2
14.58
1460
9358
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
111
156
7.36
75.13
1.8
1.2
mmol/l
2.5
2.1
1.40
104
147
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
95
112
8.74
74.52
2.1
2.0
%
10.7
13.1
0.80
45
59
(3013115) Eosinophils [#/volume] in Blood
1611
11045
2.04
74.47
10.5
5.8
e9/l
0.1
0.2
47.96
1399
9633
(1175426) CD3 cells/100 lymphocytes in Blood
95
115
8.51
72.96
2.2
2.0
%
73.1
71.3
0.37
90
109
(3018418) pH of Serum or Plasma
1013
5910
2.10
72.61
5.0
3.2
ph
7.4
7.4
0.16
203
1057
(3036481) Cortisol [Moles/volume] in Serum or Plasma
455
1893
2.67
71.54
2.9
1.8
nmol/l
340.1
362.8
0.69
434
1711
(3032080) INR in Blood by Coagulation assay
1311
8442
2.02
71.24
7.0
9.6
inr
1.1
1.3
12.49
380
2454
(40758558) Short blood count panel - Blood
880
4982
2.10
67.37
13.9
5.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
417
1731
2.65
65.52
7.7
8.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
55
34
16.47
65.08
6.7
3.9
umol/l
46.0
40.4
0.61
47
28
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
75
80
9.60
63.47
3.1
2.8
umol/l
28.9
30.2
0.37
59
57
(40768795) Lymph node Pathology biopsy report
58
47
12.57
59.03
1.3
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
413
1832
2.46
55.98
5.4
7.2
mmol/l
7.4
10.2
13.45
391
1738
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2059
16186
1.96
55.58
14.3
5.4
u/l
77.9
76.8
0.50
2000
14983
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1885
22535
0.53
54.20
4.2
5.0
mmol/l
2.8
2.7
1.64
1717
20797
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
276
1019
2.89
53.92
11.6
10.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
275
1021
2.87
53.16
3.3
1.5
ug/l
24.4
3.5
0.63
211
751
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1845
22112
0.54
51.32
3.9
4.5
mmol/l
4.7
4.6
0.98
1683
20515
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
78
114
7.00
50.90
2.2
2.2
e6/l
503.0
464.4
0.23
65
98
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
76
109
7.13
50.46
2.2
2.2
e9/l
0.2
0.2
1.38
65
97
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1831
21949
0.54
49.94
3.8
4.4
mmol/l
1.4
1.4
0.18
1677
20235
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
75
108
7.10
49.61
1.2
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
392
1791
2.38
49.42
6.5
6.9
mmol/l
1.4
1.4
0.29
374
1716
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
633
3579
1.98
46.05
4.5
2.1
mmol/l
2.4
2.4
0.38
573
3039
(3021589) Normoblasts [#/volume] in Blood
1318
9412
1.74
44.54
16.0
8.4
e9/l
0.0
0.0
1.02
1065
7661
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
44
36
12.39
44.45
2.0
2.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
476
2490
2.09
42.63
6.8
6.5
mmol/l
104.8
104.2
1.75
471
2424
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1002
6709
1.76
41.87
5.0
2.8
u/l
32.5
36.7
0.72
962
6343
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1778
21195
0.58
41.46
3.6
4.0
mmol/l
1.3
1.3
0.09
1635
19391
(3032352) Blasts [#/volume] in Cerebral spinal fluid
45
5
91.44
40.87
1.3
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
872
5687
1.76
39.46
3.2
3.0
e6/l
0.5
0.4
0.40
679
4243
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
580
3350
1.92
38.89
2.1
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
47
52
9.17
38.65
1.9
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
68
115
6.03
38.57
1.2
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
123
341
3.72
38.27
4.2
5.9
iu/ml
543.3
645.7
0.09
20
45
(36304419) Bacteria [Presence] in Urine
853
5569
1.76
38.23
3.2
2.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1736
20632
0.60
36.65
5.1
5.8
mmol/mol
39.5
40.1
1.98
1611
19112
(3002582) Erythrocytes [#/volume] in Urine
927
6262
1.71
36.40
3.2
3.1
e6/l
32.6
84.1
2.73
717
4753
(3003694) ABO and Rh group [Type] in Blood
835
5519
1.72
35.30
1.3
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
122
357
3.52
35.03
3.1
5.2
umol/l
344.5
363.7
0.74
113
312
(3019060) Gas panel - Arterial blood
297
1388
2.27
35.00
9.5
4.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
335
1656
2.16
34.35
4.9
3.9
%
1.5
0.8
5.24
156
357
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
431
2347
1.98
34.00
1.9
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
127
389
3.37
33.97
3.0
2.0
u/ml
30.7
155.0
0.84
109
311
(3004809) Band form neutrophils/100 leukocytes in Blood
96
243
4.05
33.95
3.5
2.7
%
2.1
1.1
1.22
78
177
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
99
258
3.94
33.64
6.0
7.0
mg/l
9.6
11.8
4.98
93
235
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
431
2356
1.97
33.60
2.0
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
284
1334
2.25
33.01
12.4
6.5
mmol/l
25.2
24.5
3.13
261
1243
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
57
96
6.04
32.47
3.2
2.4
%
40.3
44.8
0.86
26
35
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
60
107
5.70
32.23
1.9
1.1
%
64.5
53.7
0.57
22
12
(3026782) Osmolality of Urine
638
4013
1.76
31.67
2.9
2.6
mosm/kgh2o
537.2
549.5
0.74
567
3379
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
46
65
7.17
30.94
1.7
1.1
%
16.8
28.9
—
19
7
(3045142) Bone marrow Pathology biopsy report
69
145
4.85
30.89
1.3
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
132
440
3.10
30.72
14.9
6.7
mmol/l
10.7
11.4
1.71
114
397
(3018572) Chloride [Moles/volume] in Blood
132
441
3.09
30.60
14.9
6.7
mmol/l
105.5
105.3
0.15
114
398
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
85
213
4.08
30.49
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1876
21585
0.62
29.72
4.3
4.5
mmol/l
5.9
6.0
1.04
1700
19640
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
62
124
5.09
29.40
2.4
2.1
e6/l
608.2
861.6
1.60
25
49
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
60
121
5.04
28.19
1.1
1.1
u/l
1.8
1.1
0.96
35
63
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
182
755
2.51
27.94
2.0
2.3
ug/l
428.8
762.6
0.56
171
707
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
25
18
14.00
27.08
1.4
3.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
79
205
3.93
27.04
1.6
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
275
1379
2.10
26.95
1.4
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
254
1237
2.15
26.85
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1013
7419
1.56
26.80
3.7
3.5
e6/l
56.8
103.7
2.71
753
5142
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
157
620
2.62
26.68
3.3
4.0
u/ml
0.4
0.3
0.97
94
370
(3003458) Phosphate [Moles/volume] in Serum or Plasma
449
2669
1.81
26.58
5.5
5.7
mmol/l
1.0
1.0
0.51
420
2466
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
25
19
13.26
26.26
7.3
1.1
u/ml
104.8
17.2
0.67
25
19
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
41
62
6.69
25.93
5.0
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
510
3186
1.73
25.33
2.8
2.8
e6/l
2.3
2.5
0.22
275
1690
(3002179) Metamyelocytes/100 leukocytes in Blood
292
1532
2.01
25.25
4.6
3.7
%
0.8
0.5
1.44
102
258
(3000060) B lymphocytes [#/volume] in Blood
35
46
7.69
25.06
2.3
2.2
e6/l
330.6
326.0
0.01
18
30
(3021440) Promyelocytes/100 leukocytes in Blood
299
1594
1.98
24.69
5.0
3.9
%
0.2
0.1
2.22
142
329
(3026008) Bacteria identified in Urine by Culture
853
6099
1.57
24.64
3.2
3.1
—
—
—
0
0
(3002256) Pathology report gross observation
308
1669
1.95
24.24
1.4
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
279
1463
2.00
24.13
3.1
2.3
g/l
8.8
10.6
10.49
255
1331
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
535
3448
1.68
23.52
2.7
2.7
e6/l
1.1
1.2
0.39
300
1945
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
71
189
3.83
23.48
1.7
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
187
853
2.27
23.18
11.8
4.6
%
1.6
1.7
0.88
169
803
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
142
573
2.55
23.10
1.9
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
367
5934
0.56
23.08
1.7
1.6
mmol/l
1.4
1.4
0.13
317
4998
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
19
11
17.38
22.91
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
45
85
5.36
22.77
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
66
171
3.93
22.67
3.7
3.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
64
164
3.97
22.33
1.1
1.1
mg/l
91.0
37.7
1.26
53
135
(3007930) Methemoglobin/Hemoglobin.total in Blood
183
842
2.25
22.22
12.0
4.7
%
1.0
0.9
4.35
165
793
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
44
84
5.30
22.01
1.1
1.1
ng/l
1019.6
132.9
0.72
14
20
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
62
157
4.01
21.98
1.1
1.1
mg/l
599.9
265.0
1.26
53
136
(3031040) Bacteria [#/volume] in Urine by Automated count
1668
13915
1.47
21.95
4.8
4.3
e6/l
2379.8
2106.1
0.05
23
217
(3023183) Ammonium ion [Moles/volume] in Plasma
114
427
2.74
21.52
1.9
3.1
umol/l
32.3
37.6
1.10
92
369
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
40
72
5.62
21.32
1.4
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
150
645
2.40
21.29
13.7
5.7
mmol/l
1.5
1.3
1.50
129
574
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
21
17
12.43
21.19
1.3
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
64
172
3.78
20.90
3.0
2.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
109
407
2.74
20.71
2.0
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
21
18
11.74
20.46
1.5
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
88
296
3.03
20.22
2.1
1.5
—
—
—
0
0
(4027681)
53
128
4.20
20.04
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
59
155
3.86
19.91
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
364
2209
1.74
19.72
1.6
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
355
2143
1.75
19.59
2.9
2.6
umol/l
7.2
7.8
0.27
301
1849
(3012501) Base excess in Blood by calculation
114
449
2.60
19.51
4.0
4.3
mmol/l
2.4
2.5
0.30
82
284
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
41
7.13
19.50
1.3
1.4
—
—
—
0
0
(3010421) pH of Blood
128
537
2.45
19.19
3.9
4.0
ph
7.4
7.4
0.10
113
443
(3042111) Morphology [Interpretation] in Bone marrow Narrative
77
247
3.17
19.19
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
101
378
2.73
19.12
1.5
1.7
—
—
—
0
0
(3036489) Thrombin time
163
763
2.20
18.98
2.4
2.3
s
21.5
21.3
0.20
148
675
(3000850) Epithelial cells [#/volume] in Urine
622
4359
1.54
18.85
2.8
2.5
e6/l
5.2
5.4
0.12
567
3782
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
107
417
2.63
18.72
2.0
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
19
16
11.94
18.69
7.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
228
1229
1.93
18.11
1.6
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
70
220
3.24
18.06
1.6
1.4
mosm/kgh2o
284.2
279.7
0.83
61
163
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
16
11
14.62
17.62
1.0
1.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
334
2048
1.71
17.34
5.3
3.7
kpa
5.7
5.9
2.67
324
1975
(1761868) Lipid panel - Serum or Plasma
563
7734
0.66
16.68
2.7
2.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
262
1517
1.80
16.60
5.2
4.0
%
0.1
0.4
0.46
114
284
(3002032) Base excess in Venous blood by calculation
329
2043
1.69
16.26
5.4
3.8
mmol/l
2.1
1.9
0.69
277
1640
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
238
1350
1.83
16.12
1.9
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
137
643
2.19
15.87
5.7
4.1
mmol/l
3.8
3.9
1.76
132
604
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
76
272
2.84
15.70
1.2
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
22
29
7.64
15.69
1.9
1.1
%
55.9
44.3
0.37
13
12
(3042936) Bacteria identified in Isolate by Culture
427
2857
1.58
15.62
2.0
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
55
163
3.42
15.61
1.9
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
38
88
4.36
15.21
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
72
255
2.87
15.17
2.0
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
46
125
3.72
14.86
1.5
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
145
715
2.08
14.81
4.8
3.3
g/l
0.2
0.3
2.46
104
264
(3009214) Lutropin [Units/volume] in Serum or Plasma
117
530
2.26
14.79
2.2
1.5
u/l
7.5
8.1
0.22
93
427
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
194
1070
1.87
14.36
6.2
4.2
mmol/l
24.9
24.1
3.29
178
957
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
60
198
3.07
14.33
1.3
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
329
2114
1.63
14.18
4.5
3.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
150
767
2.01
13.89
2.0
1.7
ug/l
1.0
1.6
0.65
126
665
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
104
461
2.30
13.85
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
104
461
2.30
13.85
1.5
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
278
1722
1.68
13.82
5.3
3.2
kpa
4.8
4.6
0.42
269
1652
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
261
1591
1.70
13.77
2.1
2.2
g/l
0.2
0.2
2.89
242
1444
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
125
600
2.13
13.71
2.3
2.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
98
427
2.34
13.59
2.1
2.3
%
16.7
16.7
0.01
43
224
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
119
564
2.16
13.49
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
529
7104
0.69
13.27
3.8
4.0
mg/mmol
13.0
8.7
1.01
327
4550
(3012516) Albumin [Mass/volume] in Urine
497
6744
0.68
13.16
3.1
3.3
mg/l
695.4
213.3
1.04
324
4338
(3007853) Bacteria identified in Skin by Aerobe culture
366
2460
1.56
13.00
1.7
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1042
8501
1.35
12.88
3.9
3.7
ng/l
86.9
90.9
0.02
788
5863
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
23
40
5.79
12.72
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
543
7211
0.70
12.69
3.0
3.3
mmol/l
7.9
7.7
0.54
447
6085
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
84
353
2.42
12.65
1.4
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
135
690
2.00
12.54
2.1
1.4
iu/l
22.8
25.6
0.49
115
582
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
217
3485
0.59
12.37
1.3
1.2
u/ml
16.8
14.3
0.16
76
1366
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
57
200
2.89
12.28
2.0
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
17
8.86
12.00
1.1
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
25
50
5.03
11.93
2.1
2.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
27
58
4.69
11.88
2.2
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2353
24907
0.70
11.87
36.3
18.2
e9/l
6.9
6.7
3.66
2289
24031
(3000963) Hemoglobin [Mass/volume] in Blood
2353
24907
0.70
11.87
36.7
18.2
g/l
132.9
137.0
33.75
2327
24456
(3026361) Erythrocytes [#/volume] in Blood
2353
24901
0.70
11.76
36.3
18.1
e12/l
4.4
4.5
33.17
2285
24027
(3035941) MCH [Entitic mass]
2353
24899
0.70
11.73
36.2
18.0
pg
30.5
30.3
4.96
2321
24449
(3024731) MCV [Entitic volume]
2353
24898
0.70
11.71
36.3
18.1
fl
91.4
90.9
4.81
2323
24446
(40758292) HTLV I+II Ab panel - Serum
14
15
9.37
11.65
1.3
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2352
24884
0.70
11.61
36.4
18.1
e9/l
239.0
248.0
7.88
2288
24099
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
44
138
3.22
11.49
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
96
447
2.19
11.42
3.5
3.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
17
24
7.12
11.41
1.1
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
393
2756
1.49
11.39
1.5
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
254
1623
1.62
11.15
5.8
2.8
mmol/l
1.2
1.2
1.10
235
1362
(3051651) Icteric interference index of Serum or Plasma
37
106
3.52
11.13
5.4
4.2
—
—
—
0
0
(3020891) Body temperature
158
890
1.82
10.97
6.1
4.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
35
100
3.53
10.58
1.2
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
116
601
1.97
10.41
4.2
3.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
20
37
5.43
10.39
1.3
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
110
560
2.00
10.38
2.9
2.6
%
199.7
182.1
1.10
104
535
(3027945) Reticulocytes/100 erythrocytes in Blood
341
2367
1.50
10.35
2.9
2.4
%
1.8
1.8
0.40
310
2074
(3017354) Segmented neutrophils/100 leukocytes in Blood
46
158
2.94
10.34
2.5
2.7
%
67.1
57.8
1.96
32
97
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
569
4348
1.38
10.25
3.4
3.8
ng/l
161.5
569.0
3.84
448
3425
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
306
2.35
10.17
1.6
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
246
3673
0.64
10.15
1.3
1.3
iu/ml
34.1
36.4
0.12
80
1127
(44806118)
56
216
2.62
10.14
1.7
1.5
—
—
—
0
0
(44790048)
56
216
2.62
10.14
1.7
1.5
—
—
—
0
0
(44790047)
56
216
2.62
10.14
1.7
1.5
—
—
—
0
0
(44790049)
56
216
2.62
10.14
1.7
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
18
31
5.84
10.06
1.1
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
27
67
4.06
9.95
2.4
2.2
u/ml
510.0
5562.7
—
5
7
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
35
105
3.36
9.85
4.0
1.7
nmol/l
5.9
3.6
0.65
35
99
(46235355) HIV 1 and 2 tests - Meaningful Use set
467
3477
1.41
9.77
1.6
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
27
68
4.00
9.76
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
81
377
2.18
9.70
4.9
3.4
%
57.7
57.2
0.10
81
377
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
117
624
1.91
9.67
2.9
3.0
%
101.7
90.6
5.13
111
590
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
84
400
2.13
9.50
1.3
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
20
41
4.90
9.30
1.2
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1194
13680
0.78
9.22
2.8
2.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1872
20310
0.78
9.17
4.8
4.5
mu/l
1.8
2.1
2.45
1730
18516
(3030905) Polymorphonuclear cells [#/volume] in Blood
78
368
2.15
9.05
4.0
3.2
e9/l
4.5
4.1
0.55
78
368
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
51
4.34
8.86
1.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
15
8.03
8.86
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
99
3.26
8.61
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
222
1464
1.56
8.54
2.2
2.4
au/ml
11.7
25.1
—
6
75
(40760892) CBC W Ordered Manual Differential panel - Blood
590
4665
1.33
8.35
7.6
4.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
8
0
+∞
8.33
1.0
0.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
54
226
2.42
8.32
1.6
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
39
141
2.79
8.06
1.3
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
51
4.14
7.99
2.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
152
2401
0.61
7.97
1.7
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
63
290
2.20
7.82
1.1
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
21
52
4.06
7.79
1.6
3.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
24
66
3.66
7.73
1.2
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
179
1155
1.59
7.58
2.4
1.5
g/l
1.7
1.2
0.82
164
1053
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
24
67
3.60
7.57
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
25
5.62
7.54
1.1
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
249
1730
1.48
7.51
3.0
2.3
e9/l
71.2
69.8
0.25
193
1318
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
52
225
2.33
7.48
1.9
1.5
nmol/l
0.2
0.4
2.04
41
190
(3024869) Neuronal Ab [Presence] in Serum
16
33
4.87
7.40
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
69
3.50
7.26
1.2
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
156
987
1.61
7.19
3.2
2.6
%
0.7
0.7
0.12
148
945
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
178
1163
1.57
7.16
3.1
2.9
pmol/l
4.2
4.5
3.24
163
1011
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
20
51
3.94
7.15
2.1
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
20
51
3.94
7.15
2.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1643
14916
1.24
7.07
4.7
4.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
20
52
3.87
6.97
3.3
6.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
158
1011
1.60
6.95
3.2
2.7
%
1.2
1.2
0.52
158
1003
(3051611) Lipemic interference index of Serum or Plasma
45
189
2.40
6.94
4.9
3.9
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
24
5.44
6.76
1.1
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
100
571
1.78
6.76
12.0
4.3
mg/l
1.4
1.5
0.61
93
519
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
69
1290
0.52
6.74
1.3
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
111
655
1.72
6.69
1.8
1.5
u/ml
33.8
27.4
0.40
106
624
(3042631) Mycobacterium sp identified in Specimen
51
231
2.23
6.63
1.9
2.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
34
128
2.68
6.57
1.3
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
71
368
1.95
6.50
1.3
1.5
u/ml
91.5
106.2
0.63
16
69
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
56
266
2.13
6.49
1.7
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
110
658
1.70
6.33
2.3
1.7
mu/l
386.7
293.3
1.31
105
596
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
41
173
2.39
6.29
1.9
1.2
ug/l
3.1
3.0
0.05
34
154
(3037692) Legionella sp identified in Specimen by Organism specific culture
21
61
3.46
6.28
1.3
1.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
9
5
18.05
6.26
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
26
5.02
6.22
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
35
138
2.55
6.19
2.2
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
122
756
1.64
6.15
1.8
1.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
62
3.40
6.13
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
132
2023
0.64
6.07
1.4
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
148
977
1.54
5.74
4.7
3.7
%
50.5
49.1
0.29
148
961
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
24
81
2.98
5.68
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
244
1782
1.40
5.66
2.1
2.3
u/l
34.9
65.1
0.58
203
1513
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
194
1359
1.46
5.65
3.9
4.4
mmol/l
2.0
1.7
0.52
155
965
(3028433) Virus identified in Specimen by Culture
22
71
3.11
5.61
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
52
256
2.05
5.54
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
236
2.09
5.53
1.8
1.4
—
—
—
0
0
(3019225) pH of Specimen
271
2029
1.37
5.42
4.5
3.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
14
34
4.13
5.35
1.6
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
133
872
1.55
5.34
1.9
1.9
u/l
34.7
39.3
2.02
119
753
(3008536) Aspergillus sp Ab [Presence] in Serum
12
26
4.63
5.25
2.0
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
197
1406
1.43
5.22
3.9
4.5
ph
7.4
7.4
0.64
29
159
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
76
435
1.77
5.18
2.0
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
531
6352
0.80
5.11
3.6
3.6
%
23.1
23.9
0.53
249
2890
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
23
4.80
5.01
1.1
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
71
2.97
4.98
2.1
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
71
2.97
4.98
2.1
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
71
2.97
4.98
2.1
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
71
2.97
4.98
2.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
34
148
2.31
4.93
2.2
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
34
148
2.31
4.93
2.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
34
148
2.31
4.93
2.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
131
1919
0.67
4.89
1.6
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
197
1428
1.41
4.80
4.0
4.4
kpa
5.2
5.2
0.39
188
1310
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
124
821
1.53
4.80
2.2
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
140
2010
0.68
4.72
1.4
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
50
261
1.93
4.59
1.5
1.9
—
1264.0
—
0
10
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
26
4.24
4.35
1.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
22
83
2.66
4.32
3.6
3.1
ug/l
1.5
1.7
0.16
22
72
(3020191) Ethanol [Moles/volume] in Serum or Plasma
38
186
2.06
4.19
1.3
1.4
promille
1.0
1.3
0.40
27
140
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
27
4.08
4.16
1.7
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
103
2.44
4.13
2.0
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
693
7907
0.84
4.00
4.1
3.6
ug/l
3.0
2.5
0.43
613
7098
(3024891) Influenza virus A+B Ag [Presence] in Specimen
91
588
1.57
3.98
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
61
357
1.72
3.93
1.7
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
226
1734
1.33
3.90
4.4
3.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
46
815
0.56
3.88
1.8
1.7
mg/l
4.3
4.2
0.01
36
561
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
394
4731
0.81
3.83
1.2
1.3
u/ml
1.9
1.7
0.09
91
1258
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
22
89
2.48
3.79
2.1
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
37
187
1.99
3.77
1.3
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
90
2.45
3.71
2.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
22
90
2.45
3.71
1.1
1.1
miu/ml
1230.3
1603.7
0.76
22
90
(3000494) Fungus identified in Specimen by Culture
304
2444
1.27
3.71
1.5
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
25
4.01
3.69
2.2
2.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
12
6.68
3.67
1.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
29
136
2.14
3.61
3.6
3.4
mu/l
22.8
28.4
0.24
29
129
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
38
694
0.54
3.58
1.3
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
814
9093
0.85
3.56
2.0
2.0
pmol/l
93.7
94.7
0.25
445
4733
(3024928) Oxygen saturation in Venous blood
73
461
1.60
3.56
4.0
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
613
0.52
3.53
1.3
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
10
26
3.86
3.52
1.1
2.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
17
5.31
3.51
1.7
4.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
46
789
0.58
3.48
1.5
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1580
16796
0.87
3.47
4.3
3.8
pmol/l
14.8
14.8
0.32
1465
15224
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
36
187
1.94
3.43
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
64
396
1.63
3.40
2.1
3.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
197
1.89
3.29
2.5
2.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
115
2.18
3.28
1.1
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
204
1584
1.31
3.28
2.5
2.3
nmol/l
11.5
14.3
5.78
173
1396
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
16
60
2.68
3.22
1.1
1.1
%
79.8
105.2
1.80
16
54
(3020630) Protein [Mass/volume] in Serum or Plasma
210
1643
1.30
3.20
3.7
1.5
g/l
65.4
66.8
1.63
189
1469
(40761511) CBC panel - Blood by Automated count
2233
23096
0.85
3.18
20.7
11.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
24
110
2.19
3.18
1.5
14.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1946
20316
0.87
3.06
27.2
13.6
%
38.9
40.0
6.35
1387
14416
(3013139) Helicobacter pylori Ag [Presence] in Stool
102
1425
0.71
3.04
1.2
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
45
2.90
3.02
1.2
2.4
umol/l
21.3
18.6
0.31
13
45
(4094501)
34
607
0.55
3.02
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
65
417
1.57
3.02
1.3
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
382
0.44
3.00
1.2
1.1
u/ml
4.5
5.0
—
10
208
(3048689) Calprotectin [Mass/mass] in Stool
203
2543
0.78
2.87
2.5
2.4
ug/g
201.1
149.1
0.62
172
2009
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
13
5.39
2.87
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
382
4470
0.83
2.84
2.6
2.6
ug/l
0.7
0.7
0.17
259
2871
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
216
2681
0.79
2.83
1.6
1.8
%
1.8
1.5
2.85
182
2374
(3040151) Glucose [Moles/volume] in Capillary blood
44
260
1.70
2.83
15.8
6.6
mmol/l
7.1
7.4
0.32
36
214
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
288
0.38
2.82
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
98
1359
0.71
2.82
1.3
1.3
u/ml
261.1
235.4
0.12
91
1249
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
371
0.45
2.80
1.2
1.1
u/ml
1.7
1.4
—
9
171
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
59
2.55
2.78
1.1
1.0
%
89.3
89.3
—
6
29
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
36
202
1.79
2.77
1.7
1.8
u/ml
57.9
52.0
0.07
31
179
(3004588) Protein electrophoresis panel - Serum or Plasma
178
1392
1.30
2.75
2.8
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
327
2745
1.22
2.74
2.5
2.6
%
24.0
23.2
0.38
282
2326
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
170
2160
0.77
2.71
1.8
2.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
419
0.50
2.70
1.2
1.1
u/ml
6.5
1.9
0.38
11
186
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
296
0.40
2.70
1.2
1.1
u/ml
1.4
3.8
—
7
124
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
15
61
2.47
2.61
1.1
1.0
%
95.7
89.0
—
6
30
(3013707) Erythrocyte sedimentation rate by Westergren method
1540
16247
0.89
2.61
4.0
4.1
mm/h
12.6
11.6
1.56
1436
15022
(3001019) Free T4 and TSH panel - Serum or Plasma
67
980
0.68
2.61
1.4
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
29
155
1.88
2.61
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
137
1042
1.33
2.60
4.4
4.8
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
15
4.67
2.59
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
121
904
1.35
2.59
5.0
4.9
mmol/l
25.4
24.6
1.95
116
833
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
20
4.01
2.56
1.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
20
4.01
2.56
1.0
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
7
7.15
2.55
8.8
5.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
11
5.46
2.54
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
273
0.40
2.53
1.2
1.1
u/ml
3.6
4.1
—
6
119
(3020393) Adenovirus Ag [Presence] in Stool
10
33
3.04
2.52
1.4
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
153
1944
0.77
2.46
1.7
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
831
9067
0.88
2.41
2.6
2.8
ug/l
184.1
123.2
3.35
769
8358
(3015235) Bicarbonate [Moles/volume] in Capillary blood
80
566
1.42
2.39
2.3
3.9
mmol/l
24.7
25.0
0.23
73
495
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
28
153
1.84
2.38
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
210
1710
1.25
2.37
3.3
2.3
ml/min/173m2
65.5
66.7
0.13
62
656
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
59
395
1.50
2.33
1.3
1.4
u/ml
273.5
255.4
0.13
37
240
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2308
23688
0.87
2.32
17.8
8.8
u/l
30.1
26.7
11.66
2260
22707
(3014271) Vancomycin [Susceptibility]
22
112
1.97
2.30
3.0
2.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1836
19107
0.89
2.30
32.3
16.1
g/l
333.8
332.9
3.16
1814
18934
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
225
2712
0.81
2.29
3.9
4.6
%
31.5
32.4
0.71
173
1810
(3048929) Epstein Barr virus Ab [Presence] in Serum
88
639
1.39
2.28
1.3
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
41
254
1.62
2.27
3.1
2.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
32
186
1.73
2.24
1.2
1.2
u/l
59.8
74.1
0.34
23
127
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
229
2746
0.82
2.22
1.4
1.4
—
—
—
0
0
(4010399)
119
1539
0.76
2.22
1.3
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
9
5.56
2.21
1.4
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
9
5.56
2.21
7.4
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1513
14354
1.11
2.19
3.8
3.0
u/l
65.1
46.5
4.91
1434
13288
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
81
585
1.40
2.18
3.4
1.5
mg/l
32.9
44.9
0.50
65
463
(3034860) Kappa light chains.free [Mass/volume] in Serum
81
586
1.39
2.16
3.4
1.5
mg/l
40.3
44.5
0.27
64
464
(1761482) Bacteria [#/volume] in Urine by Culture
75
536
1.41
2.15
4.8
4.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
14
4.29
2.15
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
25
137
1.83
2.13
1.8
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
314
3636
0.85
2.08
1.4
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
407
0.56
2.07
1.3
1.5
—
—
—
0
0
(4146454)
12
263
0.45
2.07
2.3
2.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
327
0.52
2.03
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
18
90
2.01
2.00
2.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
18
90
2.01
2.00
2.2
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
19
351
0.54
2.00
1.2
1.1
u/ml
7.0
2.4
—
5
94
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
117
909
1.30
1.98
1.8
1.7
g/l
1.7
1.5
0.94
98
777
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
7
21
3.34
1.96
1.1
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
64
2.19
1.94
1.3
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
61
429
1.43
1.94
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
29
172
1.69
1.93
2.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
39
2.57
1.92
1.2
1.0
—
—
—
0
0
(3000492) Spirometry study
170
2066
0.81
1.91
1.5
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
341
2975
1.17
1.89
2.4
2.5
g/l
2.3
2.3
0.38
319
2742
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2274
22145
1.13
1.87
25.5
12.5
mg/l
21.7
23.2
1.58
2071
17142
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
52
2.31
1.87
1.2
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
74
543
1.37
1.86
2.2
1.4
g/l
0.0
0.0
0.00
64
496
(3013512) EKG study
679
6213
1.12
1.85
3.9
3.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
31
490
0.63
1.83
1.5
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
40
2.50
1.83
1.2
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
20
108
1.86
1.81
2.6
3.5
%
102.9
95.9
0.30
20
102
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
23
3.05
1.80
2.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
287
0.52
1.79
2.6
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
373
0.59
1.74
1.3
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
28
170
1.65
1.73
1.4
1.5
e6/l
26380.6
60757.2
0.41
16
101
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
244
0.49
1.73
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
372
0.59
1.73
1.3
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
24
2.92
1.72
1.1
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
371
0.59
1.71
1.3
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
28
171
1.64
1.70
5.2
2.3
%
11.9
11.2
0.28
28
171
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
370
0.59
1.70
1.3
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
36
540
0.66
1.69
1.5
1.6
e6/l
8917.6
13912.6
0.88
28
395
(3019150) Specific gravity of Urine by Refractometry
437
4862
0.88
1.69
4.0
4.0
kg/l
1.0
1.0
0.43
79
706
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
84
1092
0.76
1.69
1.0
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
72
536
1.35
1.68
2.2
1.4
g/l
0.0
0.0
0.00
64
495
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
95
737
1.30
1.67
2.0
1.4
g/l
9.9
10.4
0.43
80
621
(4281824)
19
104
1.83
1.67
1.2
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
25
2.80
1.65
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
25
2.80
1.65
1.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
25
2.80
1.65
1.4
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
367
3256
1.15
1.64
2.4
2.5
umol/l
13.5
13.4
0.01
340
2991
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
130
0.38
1.62
1.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
315
0.57
1.62
1.3
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
77
583
1.33
1.62
2.1
1.4
g/l
0.0
0.0
0.34
67
535
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
34
222
1.54
1.59
1.4
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
20
3.00
1.58
1.3
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
18
99
1.82
1.57
1.1
1.2
iu/ml
—
4.3
—
0
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
434
4805
0.89
1.56
1.6
1.7
pmol/l
55738194.6
39458252.3
0.16
366
3984
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
708
6552
1.11
1.56
2.7
2.3
u/l
58.3
59.0
0.10
661
6016
(3012441) Differential panel - Pleural fluid
26
160
1.63
1.55
1.5
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
59
432
1.37
1.55
4.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
159
0.44
1.54
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
34
224
1.52
1.54
1.4
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
34
224
1.52
1.54
1.4
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
35
233
1.51
1.51
1.4
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
128
0.39
1.49
1.4
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
72
1.95
1.48
1.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
595
6453
0.90
1.48
3.1
3.1
ng/l
951.9
1521.0
7.06
530
5478
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
42
292
1.44
1.48
1.4
1.3
nmol/l
0.6
0.6
0.09
42
279
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
23
139
1.66
1.48
1.0
1.1
nmol/l
3.8
10.6
—
6
29
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
44
309
1.43
1.47
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
305
0.59
1.46
1.3
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
45
2.23
1.46
1.4
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
53
717
0.73
1.44
1.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
16
3.13
1.44
2.0
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
34
228
1.50
1.43
1.4
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
59
2.04
1.43
3.1
2.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
302
0.59
1.42
1.3
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
37
255
1.46
1.38
1.4
1.4
pmol/l
290.5
307.4
0.19
32
191
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
60
2.00
1.38
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
145
1724
0.83
1.37
1.1
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1884
18284
1.09
1.36
31.3
14.9
%
13.9
13.6
16.52
1861
17792
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
38
264
1.44
1.36
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1595
15375
1.08
1.36
3.8
3.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
37
0.00
1.34
0.0
1.1
—
63.3
—
0
37
(3006184) Hemoglobin [Mass/volume] in Capillary blood
63
479
1.32
1.33
1.9
2.2
g/l
131.4
132.9
0.15
51
359
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
790
1.25
1.33
2.0
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
790
1.25
1.33
2.0
1.4
g/l
7.6
7.4
0.33
74
583
(3044941) Cell count panel - Synovial fluid
24
369
0.65
1.33
1.6
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
31
208
1.50
1.32
1.4
1.4
g/l
0.4
0.4
0.21
20
150
(4062490)
31
208
1.50
1.32
1.5
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
31
208
1.50
1.32
1.4
1.4
g/l
2.3
2.9
1.02
20
149
(3027135) IgG subclass 1 [Mass/volume] in Serum
31
208
1.50
1.32
1.4
1.4
g/l
6.1
6.9
0.82
20
151
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
580
0.72
1.32
2.8
2.3
ug/min
287.2
104.4
0.43
21
358
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
69
1.89
1.28
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
69
1.89
1.28
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
333
2990
1.13
1.28
17.8
27.5
inr
1.3
1.4
0.93
54
429
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
186
1.51
1.26
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
363
1.36
1.24
1.4
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
25
2.40
1.24
9.0
12.2
mmol/l
5.1
6.4
—
6
25
(3033799) Differential panel - Peritoneal fluid
9
45
2.00
1.23
1.6
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
91
735
1.25
1.23
2.0
1.4
g/l
3.1
3.1
0.01
73
572
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
790
1.24
1.22
2.0
1.4
g/l
3.6
3.9
1.05
70
558
(40757373) Influenza virus identified in Isolate
10
49
2.04
1.22
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
54
408
1.33
1.21
1.0
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
78
620
1.26
1.21
2.1
1.4
g/l
38.1
37.9
0.13
67
520
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
82
656
1.26
1.21
2.6
1.4
g/l
1.0
0.5
0.63
68
567
(4306422)
42
306
1.38
1.19
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
44
324
1.36
1.17
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
31
440
0.70
1.17
1.2
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
125
1.60
1.17
1.3
1.5
u/l
12.8
6.1
—
10
55
(3024522) Salmonella sp identified in Specimen by Organism specific culture
33
231
1.43
1.17
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
41
299
1.38
1.16
1.3
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
39
2.05
1.15
1.1
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
52
677
0.76
1.14
1.5
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
130
1099
1.19
1.14
4.1
3.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
28
192
1.46
1.11
1.4
1.5
e6/l
1293.5
1965.5
0.82
22
137
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
96
1.67
1.10
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
32
226
1.42
1.09
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
329
1.34
1.08
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
256
2853
0.89
1.07
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
557
0.75
1.07
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
28
194
1.45
1.06
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
472
5086
0.91
1.04
1.5
1.5
nmol/l
19.7
20.4
0.56
417
4302
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
839
8830
0.93
1.04
2.3
2.3
nmol/l
75.1
77.3
1.43
765
7833
(3032057) Clostridioides difficile [Presence] in Stool
9
46
1.96
1.03
4.3
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
70
863
0.81
1.01
1.5
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
64
796
0.80
1.00
1.7
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
34
460
0.74
1.00
1.1
1.2
—
7.6
—
0
39
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
35
2.00
1.00
1.7
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
115
1.57
0.99
1.2
1.2
ratio
1.1
1.1
—
6
45
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
257
1.37
0.98
1.4
1.3
nmol/l
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
92
1.63
0.97
1.9
3.2
umol/l
285.2
197.5
—
10
59
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
18
116
1.55
0.96
1.9
1.7
u/field
1.3
3.6
0.85
13
92
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
73
595
1.23
0.96
1.1
1.4
—
14.6
—
0
16
(3035320) C reactive protein [Mass/volume] in Body fluid
22
149
1.48
0.95
1.7
2.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
77
1.69
0.95
1.1
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
37
1.89
0.94
1.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
67
543
1.24
0.93
2.1
2.0
u/l
1618.6
3116.4
0.43
23
227
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
101
1.59
0.93
2.1
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
232
2087
1.12
0.92
2.2
2.4
ug/l
5.1
7.7
3.50
198
1827
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
45
348
1.30
0.91
1.2
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
69
840
0.82
0.91
1.0
1.1
—
1.5
—
0
13
(3004616) Nuclear Ab [Presence] in Serum
18
267
0.67
0.90
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2024
20627
0.94
0.89
23.1
11.3
ml/min/173m2
86.1
80.5
25.51
1781
16512
(3023511) Choriogonadotropin [Units/volume] in Urine
19
278
0.68
0.89
1.5
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
69
565
1.23
0.89
1.2
1.2
titre
49.0
93.1
—
10
52
(3044007) Cell count panel - Peritoneal fluid
8
42
1.91
0.88
1.4
2.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
34
254
1.34
0.88
1.7
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
85
1009
0.84
0.87
1.2
1.1
titre
—
253.9
—
0
26
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
92
1083
0.84
0.86
1.5
2.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
204
0.64
0.85
1.8
1.5
%
42.5
27.6
—
8
128
(3021788) Differential panel - Synovial fluid
31
412
0.75
0.84
1.7
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
90
1058
0.85
0.83
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
30
222
1.35
0.83
2.2
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
42
327
1.29
0.83
1.5
1.7
g/l
0.4
0.9
3.51
30
253
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
26
188
1.39
0.83
3.0
2.4
u/field
1.5
1.9
0.29
11
80
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
49
611
0.80
0.82
1.1
1.2
u/ml
7.8
44.3
—
5
37
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
41
319
1.29
0.82
1.1
1.2
u/ml
4.8
5.0
0.05
16
150
(3002619) Bacteria identified in Specimen by Culture
6
32
1.88
0.81
1.2
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
73
1.65
0.81
2.8
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
11
177
0.62
0.81
2.7
1.6
u/ml
13.4
23.6
—
5
43
(3044927) Protein electrophoresis panel - Urine
16
236
0.68
0.80
1.3
1.1
—
—
—
0
0
(4211845)
16
106
1.51
0.78
2.9
3.6
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
26
0.00
0.78
0.0
1.2
—
5.9
—
0
11
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
99
0.50
0.77
1.0
1.1
iu/ml
177.8
203.4
—
5
99
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
512
5426
0.93
0.77
2.1
2.3
mg/l
3.1
2.9
0.67
443
4602
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
46
572
0.80
0.77
1.5
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
267
2906
0.91
0.77
1.3
1.3
titre
610.9
551.3
0.15
44
615
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
571
0.80
0.76
1.1
1.2
u/ml
15.8
5.9
—
8
96
(3035933) Granulocytes/100 leukocytes in Blood
10
59
1.70
0.75
1.1
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
496
4674
1.07
0.75
1.9
1.8
mg/l
1.7
1.2
1.67
396
3515
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
24
2.08
0.74
1.0
1.1
mmol/l
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
24
2.08
0.74
1.0
1.2
mmol/l
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
55
1.64
0.73
1.4
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
159
0.63
0.72
31.4
17.6
nmol/l
1086.4
1384.5
—
10
154
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
13
84
1.55
0.71
1.6
1.4
umol/l
4.4
4.4
0.01
13
77
(4198724)
14
93
1.51
0.69
1.0
2.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
169
0.65
0.69
1.1
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
20
144
1.39
0.67
1.1
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
15
102
1.47
0.67
1.6
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
10
156
0.64
0.67
14.1
13.3
nmol/l
580.1
787.4
—
10
149
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
440
0.79
0.67
1.1
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
19
136
1.40
0.66
2.3
2.0
min
527.5
496.0
1.13
13
101
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
94
1.49
0.66
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
74
632
1.18
0.66
1.1
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
167
0.66
0.66
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
167
0.66
0.66
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
167
0.66
0.66
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
67
568
1.18
0.65
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
154
1.37
0.64
1.6
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
62
729
0.85
0.62
1.8
1.8
nmol/l
40.3
40.3
0.01
62
699
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
79
1.52
0.62
1.2
1.6
iu/ml
—
1465683.3
—
0
9
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
49
1.63
0.62
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
164
0.67
0.61
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
164
0.67
0.61
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
164
0.67
0.61
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
40
488
0.82
0.60
1.6
1.8
nmol/l
0.9
0.8
0.55
34
403
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
8
52
1.54
0.59
1.6
1.3
%
48.9
55.8
—
8
43
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
310
0.77
0.58
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
112
0.62
0.58
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
116
0.60
0.57
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1093
10627
1.05
0.56
3.8
3.5
estimate
0.0
0.0
0.00
236
1858
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
37
1.62
0.55
5.7
7.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
65
1.54
0.55
1.4
2.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
217
0.74
0.55
1.6
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
800
8275
0.95
0.54
4.2
3.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
125
0.64
0.54
1.1
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
97
0.62
0.52
1.3
1.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
24
188
1.28
0.51
2.3
2.3
ml
624.9
619.9
0.03
15
124
(1002224) Polysomnography panel
80
904
0.88
0.51
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
557
5799
0.95
0.50
3.1
2.4
umol/l
3865.3
5390.1
0.42
492
4997
(3023419) Bacteria identified in Sputum by Culture
34
279
1.22
0.50
1.8
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
72
633
1.14
0.49
3.4
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
182
1685
1.09
0.48
1.3
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
37
442
0.83
0.48
1.1
1.2
u/ml
7.5
48.3
—
7
40
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
119
1.35
0.48
2.7
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
48
1.46
0.46
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
298
0.80
0.45
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
72
811
0.88
0.45
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
45
524
0.86
0.45
1.9
3.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
196
2098
0.93
0.44
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
240
0.79
0.42
1.1
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
91
0.66
0.42
2.7
2.2
ug/l
28.0
107.1
—
6
81
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
92
0.65
0.42
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
70
785
0.89
0.42
2.2
2.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
14
184
0.76
0.41
1.1
1.1
—
85.1
—
0
10
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
38.1
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
16
0.00
0.41
0.0
5.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
27
326
0.83
0.41
1.2
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
333
1.17
0.40
1.2
1.2
u/ml
5.1
4.2
0.09
12
118
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1099
10754
1.04
0.40
3.9
3.6
estimate
0.0
0.0
1.08
233
1824
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
172
1606
1.08
0.39
3.9
4.0
ng/l
110.1
90.0
1.25
149
1375
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
27
324
0.83
0.39
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
60
675
0.89
0.39
1.7
1.6
iu/ml
0.0
0.2
2.15
13
137
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
207
1948
1.07
0.38
2.2
3.2
ng/l
177.5
220.1
0.94
185
1786
(3000764) Benzodiazepines [Presence] in Urine
71
790
0.90
0.38
2.2
2.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
98
1.33
0.37
3.3
3.7
—
—
—
0
0
(44806420)
9
70
1.29
0.36
2.4
2.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
70
1.29
0.36
1.7
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
43
1.40
0.35
1.8
1.4
%
4.5
2.8
—
6
37
(3019550) Sodium [Moles/volume] in Serum or Plasma
2311
22930
1.04
0.34
28.0
14.7
mmol/l
139.1
139.7
20.44
2276
22255
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
124
1333
0.93
0.34
1.2
1.2
iu/ml
158.5
143.1
0.12
39
518
(3028707) Methadone [Presence] in Urine by Screen method
39
339
1.15
0.34
3.1
3.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
12
91
1.32
0.33
2.2
2.2
ml
1979.2
2076.6
0.16
12
77
(3016879) Cocaine [Presence] in Urine
67
739
0.90
0.33
2.3
2.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
89
0.67
0.33
4.7
4.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
44
388
1.14
0.32
1.5
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
137
1.24
0.32
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
73
799
0.91
0.31
2.3
2.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
53
590
0.90
0.31
1.1
1.1
u/ml
3.0
6.1
—
6
68
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
7
52
1.35
0.31
1.1
1.2
pmol/l
264.9
236.4
—
7
36
(3041806) Other cells [#/volume] in Blood by Manual count
7
53
1.32
0.30
1.9
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
151
1421
1.07
0.30
3.5
3.0
e9/l
3.9
4.1
0.66
121
1076
(3051387) C reactive protein [Mass/volume] in Capillary blood
54
485
1.12
0.30
3.3
3.4
mg/l
36.2
26.9
0.51
30
314
(3027008) Opiates [Presence] in Urine
73
797
0.91
0.30
2.2
2.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
141
0.78
0.29
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
56
1.25
0.29
8.1
7.6
—
—
—
0
0
(4015189)
7
57
1.23
0.29
1.3
2.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
56
617
0.91
0.28
2.5
2.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
30
344
0.87
0.28
1.2
1.1
—
11.9
—
0
16
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
62
1.29
0.28
8.3
7.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
29
333
0.87
0.28
1.4
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
140
1.22
0.27
1.2
1.2
—
—
—
0
0
(44813793)
11
139
0.79
0.27
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
106
1130
0.94
0.26
2.4
2.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
72
0.69
0.26
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
54
492
1.10
0.25
2.1
2.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
76
1.18
0.24
1.0
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
6
83
0.72
0.24
1.7
4.0
mg/l
6.2
7.9
—
6
69
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
124
1.21
0.23
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
55
504
1.09
0.23
1.4
1.9
iu/l
3.5
4.6
0.44
20
173
(4268621)
26
228
1.14
0.22
2.2
2.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
40
1.25
0.22
1.2
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1079
10644
1.02
0.21
5.4
4.8
estimate
0.0
0.0
0.50
236
1892
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
1.3
—
0
10
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
11
0.00
0.21
0.0
4.6
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.2
—
7.9
—
0
11
(3007542) Rye IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
12
98
1.23
0.21
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
60
646
0.93
0.20
1.3
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
117
1.20
0.20
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
187
0.85
0.20
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
48
1.25
0.20
1.0
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
99
1.21
0.19
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2312
23007
1.02
0.19
27.7
14.8
mmol/l
4.0
4.0
4.65
2273
22287
(4034850)
83
783
1.06
0.19
10.4
9.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
15
175
0.86
0.19
1.1
1.0
mg/l
303.7
290.6
0.25
15
155
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
121
0.83
0.18
1.4
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
110
1.18
0.17
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
361
0.91
0.17
3.5
2.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
66
0.76
0.17
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
120
1149
1.05
0.17
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
60
638
0.94
0.16
1.3
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
76
0.79
0.15
4.2
4.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
77
0.78
0.15
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
140
1.14
0.15
1.3
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
13
112
1.16
0.14
1.0
1.3
nmol/l
131.6
143.5
0.38
13
112
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
60
567
1.06
0.14
1.4
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
10
84
1.19
0.14
1.6
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
180
1851
0.97
0.13
3.8
3.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
132
1.14
0.13
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
15
132
1.14
0.13
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
133
1.13
0.12
1.3
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
38
356
1.07
0.11
1.1
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
519
5120
1.02
0.11
3.6
3.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
583
5757
1.02
0.11
4.1
3.9
estimate
0.0
0.0
1.08
222
1827
(3007164) IgA [Mass/volume] in Serum or Plasma
400
4059
0.98
0.11
1.9
1.3
g/l
2.1
2.5
1.69
251
2405
(3019977) pH of Arterial blood
13
115
1.13
0.10
1.4
2.2
ph
7.4
7.4
—
5
41
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
212
1.09
0.10
2.3
4.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
5
47
1.06
0.09
1.2
1.4
mu/l
24.1
58.8
—
5
35
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
97
1.13
0.09
1.4
1.9
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
11
97
1.13
0.09
1.1
1.8
ug/l
7.0
10.6
0.61
11
80
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
61
634
0.96
0.09
1.3
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
12
107
1.12
0.08
1.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
62
0.81
0.08
1.0
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
62
0.81
0.08
1.0
2.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
34
322
1.06
0.08
1.8
2.1
—
4.0
—
0
7
(3003327) Ova and parasites identified in Stool by Light microscopy
65
673
0.96
0.08
1.8
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
145
1419
1.02
0.08
3.3
3.0
—
—
—
0
0
(3024471) HLA-A [Type]
6
73
0.82
0.07
1.0
1.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
16
174
0.92
0.07
1.1
1.3
—
300.0
—
0
6
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
372
1.05
0.07
1.1
1.1
iu/ml
1.0
101.9
—
7
83
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
137
1.10
0.07
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
83
0.84
0.07
2.6
1.3
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
9
87
1.03
0.07
1.4
1.8
nmol/l
1.0
6.8
—
9
69
(3026250) Tacrolimus [Mass/volume] in Blood
9
88
1.02
0.07
56.4
34.7
ug/l
5.9
7.6
—
9
80
(40768446) Kidney Pathology biopsy report
8
90
0.89
0.06
1.6
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
18
169
1.07
0.05
1.6
2.0
mmol/l
7.0
6.6
0.33
11
109
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
57
585
0.97
0.04
1.2
1.3
miu/ml
147.2
221.7
0.58
16
263
(3041096) Erythrocytes [Presence] in Urine by Automated
572
5688
1.01
0.04
4.1
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
285
2872
0.99
0.04
10.5
6.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
56
547
1.02
0.03
1.4
1.4
ug/g
275.3
300.8
0.50
37
320
(3019309) Folate [Moles/volume] in Red Blood Cells
425
4231
1.00
0.02
1.8
1.8
nmol/l
1136.7
1167.8
0.32
338
3182
(3015183) Erythrocyte sedimentation rate
10
107
0.93
0.02
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
15
157
0.95
0.01
1.6
1.5
g/l
0.9
1.0
0.73
15
157
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
26
253
1.03
0.01
2.0
2.3
mg/l
18.1
21.0
—
8
61
(3038177) Helicobacter pylori Ab [Presence] in Serum
33
337
0.98
0.01
1.3
1.2
—
—
—
0
0
(4024509)
20
194
1.03
0.00
1.3
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
175
0.97
0.00
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
13
128
1.02
0.00
1.2
1.4
—
1.4
—
0
7
(3025130) Human papilloma virus identified in Specimen
22
219
1.00
0.00
1.6
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
93
935
0.99
0.00
1.8
1.9
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
12
121
0.99
0.00
1.0
1.7
—
10.1
—
0
9
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
29
285
1.02
0.00
1.0
1.0
u/ml
2.4
2.6
—
9
131
(4133840)
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
1.9
—
2.0
—
0
9
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.2
—
408.0
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
87
0.92
0.00
1.4
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
0.1
—
0
9
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
60
1.00
0.00
2.2
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.6
—
0
6
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_EYE_BRAIN_NEURO_EXALLC – Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).